一、第一作者或通讯作者身份发表本专业学术论文40余篇 

1. Wang Y, Zhang XA, Yang WX, Liu XR, Xie SP, Zhang LF, Xiao XH, Xie FY, Zhu J, Lin H, Liu XM*, Xiong LX(*). Caveolin-1 Drives Ferroptosis in MDSCs via PKA-DRP1-Mediated ER‒mitochondria Crosstalk to Shape Breast Cancer Immunosuppression. Free Radical Biology and Medicine 242 (2026) 601-613. https://doi.org/10.1016/j.freeradbiomed.2025.11.001 (SCI期刊论文，一区，IF8.2)中科院二区Top

2. Zhang LF, Liu XR, Zhang XA, Xie SP, Jiang CX, Yang WX, Yin YQ, Hu Q, Hu WD, Wang YQ, Lin H*, Xiong LX(*) Caveolin-1 drives vasculogenic mimicry in lung adenocarcinoma through autophagy-mediated glycolytic reprogramming. Cellular Signalling, Volume 138, 2026, 112198, ISSN 0898-6568, https://doi.org/10.1016/j.cellsig.2025.112198. (SCI期刊论文，二区，IF3.7)中科院二区

3. Zhang LF, Wang KQ, Zhang JB, Qian XZ, Zhang XA, Wang Y, Hu Q, Zhan ZY, Hu WD,  Lin H, Liu XM*, Xiong LX(*). PDGFR-β/Cav1-induced autophagy via mTOR/FIP200/ATG13 activation in cancer-associated fibroblasts promotes the malignant progression of breast cancer. J TRANSL MED, (2025) 23:784. https://doi.org/10.1186/s12967-025-06831-6(SCI期刊论文，一区，IF7.5)中科院二区Top

4. Wang Y, Tang CY, Wang KQ, Zhang XA, Zhang LF, Xiao XH, Lin H, Xiong LX(*). The role of ferroptosis in breast cancer: Tumor progression, immune microenvironment interactions and therapeutic interventions. European Journal of Pharmacology, 2025,Volume 996, 5 June 2025, 177561.https://doi.org/10.1016/j.ejphar.2025.177561(SCI期刊论文，JCR一区中科院二区，IF4.7)

5. Feng MR, Zhang LF, Zou ZL, Xie MY, Zhang JB, Wang JY, Wang KQ, Zhu J, Xiong LX(*). Engineered Macrophage Exosomes Deliver Drug-Targeted Therapy for Breast Cancer. WIRES NANOMED NANOBI, 2024; 16:e2012. https://doi.org/10.1002/wnan.2012(SCI期刊论文，JCR一区中科院二区，IF8.2)

6. Lin Q#, Zong S#, Wang Y#, Zhou Y, Wang K, Shi F, Wang J, Feng M, Luo W, Zhang L, Lin H, Xiong LX(*). Breast cancer-derived CAV1 promotes lung metastasis by regulating integrin α6β4 and the recruitment and polarization of tumor-associated neutrophils. Int J Biol Sci 2024; 20(14):5695-5714. https://doi:10.7150/ijbs.94153.(SCI期刊论文，一区Top，IF10.0) 

7. Luo WT, Zhou YJ, Wang JY, Wang KQ, Lin Q, Li YQ, Xie YJ, Li M, Wang J, Xiong LX(*). YTHDF1’s Regulatory Involvement in Breast Cancer Prognosis, Immunity, and the ceRNA Network. Int. J. Mol. Sci. 2024, 25(3), 1879. https://doi.org/10.3390/ijms25031879(SCI期刊论文，二区，IF5.6)

8. 周油伽，罗文婷，吴溥桢，蔡立楷，邬龙源，熊丽霞。人工智能在乳腺癌诊断及预测模型中的应用，南昌大学学报（医学版），南昌大学学报（医学版），2024，64（1）：81-87.

9. Li Y#, Li M#, Su K, Zong S, Zhang H*, Xiong LX(*). Pre-metastatic niche: from revealing the molecular and cellular mechanisms to the clinical applications in breast cancer metastasis. Theranostics 2023; 13(7):2301-2318. doi:10.7150/thno.82700.   https://www.thno.org/v13p2301.htm (SCI期刊论文，一区Top，IF12.4)

10. Wang Y, Li Y, Zhong J, Li M, Zhou Y, Lin Q, Zong S, Luo W, Wang J, Wang K, Wang J, Xiong LX(*). Tumor-derived Cav-1 promotes pre-metastatic niche formation and lung metastasis in breast cancer. Theranostics 2023; 13(6):1684-1697. doi:10.7150/thno.79250.(SCI期刊论文，一区Top，IF12.4)

11. Zhong JP#, Zong SW#, Wang JY, Feng MR, Wang J, Zhang HY*, Xiong LX(*). Role of neutrophils on cancer cells and other immune cells in the tumor microenvironment. BBA- Molecular Cell Research, 2023; 1870(7): 119493. doi: 10.1016/j.bbamcr.2023.119493 (SCI期刊论文，一区，IF5.1)

12. Chen XY#, Li YQ#, Li M, Xie YJ, Wang KQ, Zhang LF, Zou ZL, Xiong LX(*). Exosomal miRNAs assist in the crosstalk between tumor cells and immune cells and its potential therapeutics. Life Sciences329 (2023) 121934. doi: 10.1016/j.lfs.2023.121934(SCI期刊论文，一区，IF6.1)

13. Huang QY#, Wu LY#, Wang Yi#, Kong XY, Xiao XH, Huang QY, Li M, Zhai YJ, SHi FX, Zhao RC, Zhong JP, Xiong LX(*). Caveolin-1-deficient fibroblasts promote migration, invasion, and stemness via activating the TGF-β/Smad signaling pathway in breast cancer cells. Acta Biochimica et Biophysica Sinica, 2022, 54(11): f page-l page. doi: 10.3724/abbs.2022150(SCI期刊论文，一区，IF3.848)

14. Shi FX#, Chen XY#, Wang Yi#, Xie YJ, Zhong JP, Su KT, Li M, Li YQ, Lin Q, Zhou YJ, Wang J, Xiong LX(*). HOTAIR/miR-203/CAV1 Crosstalk Inflfluences Proliferation, Migration, and Invasion in the Breast Cancer Cell. Int. J. Mol. Sci.2022, 23, 11755. doi: 10.3390/ijms231911755(SCI期刊论文，一区，IF5.6)

15. Guo YL#, Zhai YJ#, Wu LY, Wang YZ, Wu PZ, Xiong LX(*). Mesenchymal stem cell-derived extracellular vesicles: pleiotropic impacts on breast cancer occurrence, development, and therapy. Int. J. Mol. Sci.2022, 23, 2927. doi: 10.3390/ijms23062927 (SCI期刊论文，一区，IF5.6)

16. Wang Yi#, Zhao RC#, Jiao XQ#, Wu LY, Wei YX, Shi FX, Zhong JP, Xiong LX(*). Small Extracellular Vesicles: Functions and Potential Clinical Applications as Cancer Biomarkers. Life, 2021, 11,1044. doi: 10.3390/life11101044 (SCI期刊论文，一区，IF 3.817)

17. Lai XN#, Guo YL#, Chen MM, Wei YX, Yi WT, Shi YB, Xiong LX(*). Caveolin1: its roles in normal and cancer stem cells. J Cancer Res Clin Oncol, 2021, 147, 3459–3475.  doi: 10.1007/s00432-021-03793-2. (SCI期刊论文，三区，IF 4.553)

18. Shi YB#, Huang QY#, Kong XY, Zhao RC, Chen XY, Zhai YJ, Xiong LX(*). Current Knowledge of Long Non-Coding RNA HOTAIR in Breast Cancer Progression and Its Application. Life, 2021,11(6), 483. doi: 10.3390/life11060483(SCI期刊论文，一区，IF 3.817)

19. Tang LB#, Ma SX#, Chen ZH, Huang QY, Wu LY, Wang Y, Zhao RC, Xiong LX(*). Exosomal microRNAs: Pleiotropic Impacts on Breast Cancer Metastasis and Their Clinical Perspectives. Biology 2021, 10, 307. doi: 10.3390/biology10040307 (SCI期刊论文，二区，IF5.079)

20. Jiao XQ#, Qian XL#, Wu LY, Tang LB, Wang Y, Kong XY, Xiong LX(*). microRNA: the impact on cancer stemness and therapeutic resistance. Cells, 2020, 9(1), 8; doi：10.3390/cells9010008 (SCI期刊论文，二区，IF 5.656)

21. Shi YB#, Li J#, Lai XN, Jiang R, Zhao RC, Xiong LX(*).Multifaceted roles of Caveolin-1 in lung cancer: a  new investigation focused on tumor occurrence, development and therapy. Cancers, 2020, 12(1),291. doi:10.3390/cancers12020291(SCI期刊论文，二区，IF6.162)

22. Lai XN#, Li J#, Tang LB, Chen WT, Zhang L, Xiong LX(*). MiRNAs and lncRNAs: dual roles in TGF-β signaling regulated metastasis in lung cancer. Int. J. Mol. Sci.2020,21,1193. doi:10.3390/ijms21041193 (SCI期刊论文，二区，IF4.183)

23. Huang QY#, Liu GF#, Qian XL#, Tang LB, Huang QY, Xiong LX(*).Long non-coding RNA: dual effects on breast cancer metastasis and clinical application. Cancers, 2019, 11(11), 1802; doi：10.3390/cancers11111802 (SCI期刊论文，二区，IF6.162)

24. Qian XL, Pan YH, Huang QY, Shi YB, Huang QY, Hu ZZ*, Xiong LX(*). Caveolin 1: A multifaceted driver of breast cancer progression and its application in the clinical treatment. OncoTargets and Therapy. 2019, 12: 1539-1552. doi:  10.2147/OTT.S191317 (SCI期刊论文，三区，IF 3.046) 

25. Huang QY#, Lai XN#, Qian XL#, Lv LC, Li J, Duan Jing, Xiao XH, Xiong LX(*). Cdc42: A novel Regulator of Insulin Secretion and Diabetes-Associated Diseases. Int. J. Mol. Sci. 2019, 20,179;doi:10.3390/ijms20010179 (SCI期刊论文，三区，IF4.183) 

26. Duan J#, Qian XL#, Li J#, Xiao XH, Lu XT, Lv LC, Huang QY, Ding W, Zhang HY*, Xiong LX(*). miR-29a plays negative effects on glucose stimulate insulin secretion and MIN6 cell proliferation via Cdc42/β-catenin signaling pathway. International Journal of Endocrinology, Volume 2019, Article ID 5219782, 13 pages， DOI: 10.1155/2019/5219782 (SCI期刊论文，三区，IF 2.299)

27. Xiao XH#, Huang QY#, Qian XL#, Duan J, Jiao XQ, Wu LY, Huang QY, Li J, Lai XN, Shi YB, Xiong LX(*).  Cdc42 promotes ADSCs-derived IPCs induction, proliferation, and insulin secretion via Wnt/β-catenin signaling. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 2019, 12: 2325-2339. doi: 10.2147/DMSO.S226055 (SCI期刊论文，三区，IF 2.842)

28. Zhang Y#, Li J#, Lai XN, Jiao XQ, Xiong JP, Xiong LX(*). Focus on Cdc42 in Breast Cancer: New Insights, Target Therapy Development and Non-coding RNAs. Cells, 2019, 8(2), 146 doi:10.3390/cells8020146 (SCI期刊论文，二区，IF 5.656)

29. Zhang Y, Xie ZY, Guo XT, Xiao XH, Xiong LX(*). Notch and breast cancer metastasis: Current knowledge, new sights and targeted therapy. Oncology Letters, 2019,18: 2743-2755. doi: 10.3892/ol.2019.10653. (SCI期刊论文，四区，IF 1.871) 

30. Lv LC#, Huang QY#, Ding W, Xiao XH, Zhang HY*, Xiong LX(*). Fish gelatin: the novel potential applications. Journal of Functional Foods, 2019,63,103581. (SCI期刊论文，二区，IF3.197)

31. Xiong LX, Meng Q, Sun X, Lu X, Fu Q, Peng Q, Yang J, Oh KW, Hu ZZ (*)。Cocaine- and amphetamine-regulated transcript peptide in the nucleus accumbens shell inhibits cociane-induced locomotor sensitization to transient over-expression of α-Ca2+/ Calmodulin-dependent Protein Kinase II.  Journal of Neurochemistry2018 Jan 4. doi: 10.1111/jnc.14289.(SCI期刊论文，二区，IF 4.87他引1次) 

32. Zhang Y#, He SJ#, Mei RM#, Kang YR, Duan J, Wei R, Xiang CQ, Wu YM, Lu XT, Cai ZY, Xiong LX(*)。miR-29a suppresses IL-13-induced cell invasion byinhibiting YY1 in the AKT pathway in lung adenocarcinoma A549 cells. Oncology Report, 2018, 39: 2613-2623.     doi:10.3892/or.2018.6352 (SCI期刊论文已录用，IF 3.041 三区) 

33. Xiao XH#, LV LC#, Duan J, Wu YM, He SJ, Hu ZZ*, Xiong LX（通讯作者）. Regulating Cdc42 and its signaling pathways in cancer: small molecules and microRNA as new treatment candidates. Molecules, 2018, 23(4), 787; doi:10.3390/molecules23040787  (SCI期刊论文，IF 3.06 三区) 

34. Qian XL#, Li J#, Wei R, Lin H, Xiong LX（通讯作者）.Internal and External Triggering Mechanism of “Smart” Nanoparticle-Based DDSs in Targeted Tumor Therapy. Current Pharmaceutical Design, 2018, 24(15): 1639-1651. doi: 10.2174/ 1381612824666180510094607 (SCI期刊论文，IF 2.76 二区) 

35. Ding W, Zou GL,Zhang W, Lai XN, Chen HW, Xiong LX（通讯作者）.Interleukin-33: Its Emerging Role in Allergic Diseases. Molecules, 2018, 23(7), 1665; doi:10.3390/molecules 23071665(SCI期刊论文，三区,IF 3.06) 

36. Lu XT#, Zhang Yu#, Wei Ran#, Yu QF, Chen HW, Mei RM, He SJ, Liu XX, Xiang CQ, Huang P, Xiong JP, Xiong Lixia（通讯作者）. Effect of IL-13Rα2 on TGF-β expression and collagen synthesizing induced by IL-13 in human lung fibroblasts HFL-1. Int J Clin Exp Pathol 2017;10(6): 6845-6853. （SCI收录期刊论著，IF 1.4 四区）

37. He SJ#, Xiang CQ#, Zhang Yu, Chen HW,  Xiong Lixia（通讯作者）, et al. Recent Progress on the Effects of MicroRNAs and natural products on Tumor Epithelial-Mesenchymal Transitions. OncoTargets and Therapy. 2017,10:3435-3451. DOI: 10.2147/OTT.S139546(SCI期刊论文，三区，IF 2.66 ) 

38. Wang HL#, Xiong LX #（熊丽霞，共同第一作者）,Tang WP, Zhou Y and Li F*. A systematic review of malignancy-associated hemophagocytic lymphohistiocytosis that needs more attentions. Oncotarget, 2017, 8(35):59977-59985. doi: 10.18632/oncotarget.19230. (SCI期刊论文，一区，IF 5.168) 

39. Shi Xiaoyu#, Xiong Lixia#（熊丽霞，共同第一作者）, Xiao Liang, et al. Downregulation of caveolin-1 upregulates the expression of growth factors and regulators in co-culture of fibroblasts with cancer cells. Molecular Medicine Reports, 2016，13：744-752。DOI: 10.3892/mmr.2015.4610. （SCI收录期刊论著，四区，IF 1.692）

40. Li Wenlin#, Xiong Lixia#（熊丽霞，共同第一作者）, Shi Xiaoyu , Xiao Liang, Qi Guanyun, Meng Chang. IKKβ/NFκBp65 activated by interleukin-13 targets the autophagy-related genes LC3B and beclin 1 in fbroblasts co-cultured with breast cancer cells。EXPERIMENTAL AND THERAPEUTIC MEDICINE，2016，11：1259-1264。DOI: 10.3892/etm.2016.3054（SCI收录期刊论著，四区，IF1.4）

41. Li WL#, Xiong LX#, Liu HS, Shi XY (*). UP-REGULATION OF FSP-1 IN FIBROBLASTS CULTURED WITH BREAST CANCER CELLS AND ITS IMPACT ON BREAST, CANCER GROWTH 4th Annual Meeting of The International  Cytokine and Interferon Society (ICIS) San Francisco, CA 2016（ISTP收录）

42. Xiong Lixia, Li Wenlin, Chen Houwen, et al. bFGF gene transfected heterotopic transplantation of autologous bone marrow mononuclear cells promote wound healing of skin burn. Cell biology international, 2010, 34(8): S41.（ISTP收录）

43. 段静，肖星华，熊丽霞（通讯作者）。间充质干细胞治疗2型糖尿病的机制及研究进展。中国细胞生物学学报。2019,41 (3): 516–522. （CSCD核心期刊论著）

44. 张煜，吕枭锐，张玮，熊丽霞（通讯作者）。婴幼儿血管瘤消退期的脂肪细胞形成。重庆医科大学学报，2019，45（4）：492-496.（CSCD核心期刊论著）

45. 李君，张煜，熊丽霞（通讯作者）。Cdc42在乳腺癌中的作用。中国细胞生物学学报。2018,40（7）：1223-1230. （CSCD核心期刊论著）

46. 段静，梅任美，熊丽霞（通讯作者）。MicroRNA和YY1对肿瘤的调控作用及相互间的影响。南昌大学学报（医学版），2017,57（6）：79-83.  

47. 张煜，魏然，熊丽霞（通讯作者）。Cdc42作为功能性因子调控纤维化。中国细胞生物学学报。2017,39（3）：348-355. （CSCD核心期刊论著）  

48. 刘秀兴，黄萍，熊俊平，熊丽霞（通讯作者）。IL-13在过敏反应性疾病中的作用。细胞与分子免疫学杂志，2017，3（7）：996-1000. （CSCD核心期刊论著）

49. 何姝槿，陈厚文，熊丽霞（通讯作者）。MicroRNA对EMT的调节作用及其与肿瘤侵袭的关系。中国生物化学与分子生物学报，2016，32（11）：1197-1205. （CSCD核心期刊论著）

50. 陈厚文，余群芳，何晓燕, 熊丽霞（通讯作者）。IL-13对A549细胞IL-13Rα2表达及增殖和迁移的影响。南昌大学学报（医学版），2016,56（1）：14-20。通讯作者 第7作者（中国科技核心期刊) 被引用1次

51. 金旗，熊丽霞（通讯作者）。IL-13Rα2作为功能受体介导信号转导的研究进展. 中国病理生理杂志，2014,30(8)：1513-1518(CSCD核心库) 被引用5次

52. 熊绍恒，熊丽霞（通讯作者）。IL-13受体介导的融合蛋白在肿瘤靶向治疗中的研究进展。中国细胞生物学学报，2015，37（10）：1418-1424(CSCD核心库) 被引用0次

53. 余群芳， 蔡震宇， 朱俊， 熊丽霞（通讯作者）。siRNA干扰IL-13Rα2表达对人肺成纤维细胞TGF-β表达的影响。中国病理生理杂志，2015,31（10）：1915。(CSCD核心库) 被引用0次

54. 熊丽霞，李文林，蔡震宇，等。干扰素-γ抑制IL-13对成纤维细胞的纤维化作用。中国病理生理杂志，2013，29（3）：504-508。（CSCD核心期刊论著）

55. 熊丽霞, 李文林, 蔡震宇, 等. 白细胞介素13通过STAT6途径促进瘢痕成纤维细胞株胶原合成. 中国细胞生物学学报，2010，32（6）：868-872. （CSCD核心期刊论著）

56. 熊丽霞, 李文林，石小玉，等. 酪氨酸酶抑制剂A77 1726阻断IL-13对成纤维细胞的促胶原合成作用。细胞与分子免疫学杂志，2009，25（1）：16-19.（CSCD核心期刊论著）

57. 熊丽霞, 石小玉，李文林，等. 白细胞介素13刺激成纤维细胞胶原基因转录和胶原蛋白的合成。中国组织工程研究与临床康复，2007，11（23）：4466-4469.（国家核心期刊论著）

58. 熊丽霞, 石小玉，李文林，等.成纤维细胞胶原合成及细胞内STAT6蛋白磷酸化与白细胞介素13的促进作用。中国组织工程研究与临床康复，2007，11（1）：275-277.（国家核心期刊论著）

59. 熊丽霞，徐方云，王红梅，等。串讲教学在病理生理学教学中的作用。中国病理生理杂志，2013,29（10）：1887 (CSCD核心库)

60. 邹芳芳, 罗芳, 熊丽霞（通讯作者）. 细胞因子信号转导抑制分子3与肿瘤关系的研究进展. 南昌大学学报：医学版, 2011,51（4）：93-95. (中国科技核心期刊)

61. 何晓燕，熊丽霞（通讯作者）. IL-13Rα2在肿瘤研究中的进展。南昌大学学报（医学版），2013,53（1）：87-89。(中国科技核心期刊)